Allspring Factor Enhanced International Equity Portfolio OCSE:NOVO B Holdings History
Allspring Factor Enhanced International Equity Portfolio's Novo Nordisk AS Holding Summary
As of 2023-11-30, Allspring Factor Enhanced International Equity Portfolio held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and Allspring Factor Enhanced International Equity Portfolio now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2021Q4. And since then Allspring Factor Enhanced International Equity Portfolio has made 1 purchases of OCSE:NOVO B, at an average price of kr337.43, for a total of 133,906.00 shares. In addition, there have been 8 sales at an average price of kr569.57 for 133,906.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, Allspring Factor Enhanced International Equity Portfolio's estimated gain on his OCSE:NOVO B holdings is kr31.09 Mil, reflecting a 68.80% gain to date.
Allspring Factor Enhanced International Equity Portfolio OCSE:NOVO B (kr414.60) Holding Chart
Allspring Factor Enhanced International Equity Portfolio OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
